|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
14,310,000 |
Market
Cap: |
9.45(M) |
Last
Volume: |
26,960 |
Avg
Vol: |
26,886 |
52
Week Range: |
$0.5651 - $1.28 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for rare and life-threatening diseases. Co.'s pipeline includes four programs: ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; ACER-801 (osanetant) for the treatment of induced vasomotor symptoms; EDSIVO (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome in patients with a confirmed type III collagen mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, zika, dengue, ebola and COVID-19.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,229,508 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,500,000 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Jarkesy George |
10% Owner |
|
2005-01-25 |
4 |
S |
$8.30 |
$25,016 |
D/D |
(3,000) |
1,502,500 |
|
- |
|
Wesner Terry |
Director |
|
2005-01-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
243,572 |
|
- |
|
Wesner Terry |
officerTitle |
|
2005-01-21 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
237,295 |
|
- |
|
Jarkesy George |
10% Owner |
|
2005-01-21 |
4 |
S |
$7.59 |
$15,180 |
D/D |
(2,000) |
1,505,500 |
|
- |
|
Jarkesy George |
10% Owner |
|
2005-01-19 |
4 |
S |
$6.84 |
$21,635 |
D/D |
(3,000) |
1,507,500 |
|
- |
|
Kamin Tony |
Director |
|
2004-12-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
- |
|
Jarkesy George |
10% Owner |
|
2004-12-03 |
4 |
S |
$7.25 |
$3,625 |
D/D |
(500) |
1,510,500 |
|
- |
|
Jarkesy George |
10% Owner |
|
2004-12-02 |
4 |
S |
$7.50 |
$7,500 |
D/D |
(1,000) |
1,511,000 |
|
- |
|
Jarkesy George |
10% Owner |
|
2004-11-29 |
4 |
S |
$7.25 |
$3,625 |
D/D |
(500) |
1,512,000 |
|
- |
|
Mcwilliams David |
CEO |
|
2004-11-02 |
5 |
B |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
|
- |
|
Rouse William |
CFO |
|
2004-10-29 |
5 |
B |
$0.00 |
$0 |
D/D |
1,250 |
151,250 |
|
- |
|
Lau Warren C |
Former Director & 10% Owner |
|
2004-10-06 |
5 |
S |
$0.50 |
$150,000 |
D/D |
(220,000) |
1,078,748 |
|
- |
|
Jarkesy George |
10% Owner |
|
2004-06-04 |
4 |
A |
$14.00 |
$14,175,000 |
D/D |
1,012,500 |
1,512,500 |
|
- |
|
Fritzsche R Wayne |
VP of Corporate DevelopmentOff |
|
2004-06-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
500,000 |
|
- |
|
Adduci Jeffrey |
Director |
|
2004-06-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000 |
|
- |
|
Gow Robert H |
Director |
|
2004-06-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
342,500 |
|
- |
|
Rouse William |
Director |
|
2004-06-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
150,000 |
|
- |
|
Lau Warren C |
CEO, COO, Pres. & TreasurerOff |
|
2004-06-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,298,748 |
|
- |
|
Otteson Jason G |
CEO and CFO |
|
2004-02-01 |
4 |
B |
$0.00 |
$12,500 |
D/D |
12,500,000 |
16,090,994 |
3.15 |
- |
|
Jarkesy George |
10% Owner |
|
2003-07-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000,000 |
|
- |
|
170 Records found
|
|
Page 7 of 7 |
|
|